Rare diseases
Investigational molecules
Locations
Back to Poland18 clinical trials in Plewiska k. Poznania, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
PolandA Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
PolandStudy on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis
PolandStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
PolandStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
PolandStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
PolandPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
PolandStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PolandStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on relapsing forms of multiple sclerosis, evaluating novel therapeutic approaches and comparing treatment efficacies. Studies aim to assess new medications against established treatments for better patient outcomes.
Research includes innovative treatments targeting neurological markers and disability progression reduction.
Dedicated research examining Primary Progressive Multiple Sclerosis (PPMS), with trials evaluating higher-dose treatment protocols and their impact on disease progression.
Investigations focus on improving treatment outcomes for progressive forms of MS through innovative therapeutic approaches.
Clinical trials comparing different therapeutic interventions for multiple sclerosis, including established and novel treatments to determine optimal patient care strategies.
Research emphasizes measuring treatment effectiveness through various clinical endpoints and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
